Furthermore, BMP2 has been identified as a differentiating and radiosentizing agent for colorectal cancer stem cells, suggesting that restoring the BMP signaling pathway may offer novel therapeutic approaches for colorectal cancer (Mahmoudi et al. 2023). Here, BMP2 is linked to colorectal cancer.